EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

MoleSense

Startup in Creation

Neuchâtel, Switzerland
2 profile visits

About

At MoleSense, we are redefining women's healthcare with our ‘molecular wearables,’ a new class of medical devices that not only track biophysical and physiological biomarkers such as body temperature and heart rate but also continuously monitor chemical biomarkers like metabolites, electrolytes, proteins, and hormones that, until now, have only been measured sporadically through traditional blood tests. Our mission is to empower women with actionable insights into their reproductive health, from preconception to menopause through motherhood.

Sectors

Health/MedTech

Representatives

Gian Luca Barbruni

CEO

MoleSense